Teacher Retirement System of Texas’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $234K | Sell |
11,183
-337,167
| -97% | -$7.59M | ﹤0.01% | 1379 |
|
|
2025
Q4 | $8.01M | Buy |
348,350
+327,502
| +1,571% | +$10.8M | 0.03% | 399 |
|
|
2025
Q3 | $627K | Sell |
20,848
-1,925
| -8% | -$57.7K | ﹤0.01% | 1430 |
|
|
2025
Q2 | $828K | Buy |
22,773
+404
| +2% | +$14.6K | ﹤0.01% | 1316 |
|
|
2025
Q1 | $810K | Sell |
22,369
-2,205
| -9% | -$91.7K | ﹤0.01% | 1320 |
|
|
2024
Q4 | $1.03M | Buy |
24,574
+4,130
| +20% | +$205K | ﹤0.01% | 1087 |
|
|
2024
Q3 | $1.14M | Buy |
20,444
+4,171
| +26% | +$212K | 0.01% | 944 |
|
|
2024
Q2 | $669K | Sell |
16,273
-174
| -1% | -$7.43K | ﹤0.01% | 1088 |
|
|
2024
Q1 | $768K | Sell |
16,447
-131
| -0.8% | -$6.18K | ﹤0.01% | 1100 |
|
|
2023
Q4 | $793K | Sell |
16,578
-3,496
| -17% | -$136K | 0.01% | 1126 |
|
|
2023
Q3 | $716K | Buy |
20,074
+1,025
| +5% | +$40.6K | ﹤0.01% | 1221 |
|
|
2023
Q2 | $879K | Sell |
19,049
-1,467
| -7% | -$68K | 0.01% | 1116 |
|
|
2023
Q1 | $823K | Buy |
20,516
+341
| +2% | +$14.6K | 0.01% | 1239 |
|
|
2022
Q4 | $935K | Sell |
20,175
-1,652
| -8% | -$65K | 0.01% | 1159 |
|
|
2022
Q3 | $904K | Buy |
21,827
+11,514
| +112% | +$592K | 0.01% | 1207 |
|
|
2022
Q2 | $615K | Sell |
10,313
-3,044
| -23% | -$187K | ﹤0.01% | 1044 |
|
|
2022
Q1 | $970K | Buy |
13,357
+958
| +8% | +$66.7K | 0.01% | 1028 |
|
|
2021
Q4 | $1.04M | Buy |
12,399
+2,272
| +22% | +$185K | ﹤0.01% | 1045 |
|
|
2021
Q3 | $913K | Buy |
10,127
+2,084
| +26% | +$188K | ﹤0.01% | 1012 |
|
|
2021
Q2 | $767K | Buy |
8,043
+1,230
| +18% | +$128K | ﹤0.01% | 1029 |
|
|
2021
Q1 | $776K | Buy |
6,813
+1,679
| +33% | +$229K | ﹤0.01% | 898 |
|
|
2020
Q4 | $711K | Buy |
5,134
+1,945
| +61% | +$231K | ﹤0.01% | 812 |
|
|
2020
Q3 | $262K | Buy |
+3,189
| New | +$264K | ﹤0.01% | 971 |
|
|
2018
Q4 | – | Sell |
-5,570
| Closed | -$425K | – | 1114 |
|
|
2018
Q3 | $425K | Sell |
5,570
-3,991
| -42% | -$325K | ﹤0.01% | 994 |
|
|
2018
Q2 | $735K | Sell |
9,561
-314
| -3% | -$20.3K | ﹤0.01% | 969 |
|
|
2018
Q1 | $504K | Sell |
9,875
-3,703
| -27% | -$186K | ﹤0.01% | 1197 |
|
|
2017
Q4 | $630K | Buy |
+13,578
| New | +$666K | ﹤0.01% | 1372 |
|
|
2017
Q2 | – | Sell |
-3,010
| Closed | -$204K | – | 1061 |
|
|
2017
Q1 | $204K | Hold |
3,010
| – | – | ﹤0.01% | 938 |
|
|
2016
Q4 | $212K | Sell |
3,010
-1,000
| -25% | -$70.9K | ﹤0.01% | 919 |
|
|
2016
Q3 | $284K | Sell |
4,010
-1,075
| -21% | -$68.6K | ﹤0.01% | 1058 |
|
|
2016
Q2 | $249K | Buy |
5,085
+1,752
| +53% | +$113K | ﹤0.01% | 1263 |
|
|
2016
Q1 | $211K | Buy |
3,333
+795
| +31% | +$52K | ﹤0.01% | 1304 |
|
|
2015
Q4 | $285K | Sell |
2,538
-743
| -23% | -$74.3K | ﹤0.01% | 877 |
|
|
2015
Q3 | $316K | Buy |
3,281
+2,397
| +271% | +$274K | ﹤0.01% | 1033 |
|
|
2015
Q2 | $91K | Buy |
884
+196
| +28% | +$15.2K | ﹤0.01% | 1208 |
|
|
2015
Q1 | $43K | Buy |
688
+112
| +19% | +$6.22K | ﹤0.01% | 1545 |
|
|
2014
Q4 | $25K | Buy |
576
+308
| +115% | +$14.1K | ﹤0.01% | 1774 |
|
|
2014
Q3 | $15K | Buy |
268
+7
| +3% | +$352 | ﹤0.01% | 1984 |
|
|
2014
Q2 | $12K | Buy |
+261
| New | +$10.7K | ﹤0.01% | 2239 |
|
Other funds holding RARE
VPM
VCM
RI
SI
BG
Teacher Retirement System of Texas's RARE Position: Q1 2026 in Review
Teacher Retirement System of Texas reduced its Ultragenyx Pharmaceutical (RARE) stake by 97% in Q1 2026, selling an estimated $7.59M and leaving 11,183 shares worth $234K. The position accounts for ﹤0.01% of the portfolio, ranked #1379.
Teacher Retirement System of Texas first reported a position in RARE in Q2 2014 and has held it in 39 quarters since. The position peaked at $8.01M in Q4 2025. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.
- Teacher Retirement System of Texas held 11,183 shares of Ultragenyx Pharmaceutical worth $234K as of Q1 2026.
- Teacher Retirement System of Texas sold 337,167 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $7.59M.
- Ultragenyx Pharmaceutical made up ﹤0.01% of Teacher Retirement System of Texas's portfolio in Q1 2026, its #1379 holding.
- Teacher Retirement System of Texas first reported a position in Ultragenyx Pharmaceutical in Q2 2014 and has held it in 39 quarters since.
- Teacher Retirement System of Texas's Ultragenyx Pharmaceutical position peaked at $8.01M in Q4 2025.
- 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.
Based on Teacher Retirement System of Texas's 13F filing for Q1 2026, filed 30 Apr 2026.